Rubella Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella Vaccine
Conditions:   Human Papilloma Virus Infection Type 16;   Human Papilloma Virus Infection Type 18;   Measles;   Rubella;   Mumps Interventions:   Biological: HPV+MMR（0d），HPV（6m）;   Biological: HPV（0d），HPV（6m），MMR（7m）;   Biological: MMR（0d），HPV（1m），HPV（7m） Sponsor:   Zhejiang Provincial Center for Disease Control and Prevention Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2022 Category: Research Source Type: clinical trials

Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live
Condition:   Immunogenicity, Vaccine Intervention:   Biological: Measles, Mumps and Rubella Combined Vaccine, Live Sponsor:   Shanghai Institute Of Biological Products Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 17, 2021 Category: Research Source Type: clinical trials